S.Amdt. 2846Senate119th Congress (2025-2027)2nd degree

S.Amdt. 2846

What it does: Rewrites section 71203
Submitted July 1, 2025

What it changes

1 change to S.Amdt. 2360 · shown in S.Amdt. 2360's text

Rewrites a provision
  1. Rewrites section 71203

    Replaces

    In S.Amdt. 2360 as proposed

    Struck: SEC. 71203. EXPANDING AND CLARIFYING THE EXCLUSION FOR ORPHAN DRUGS UNDER THE DRUG PRICE NEGOTIATION PROGRAM.

    Inserted: SEC. 71203. DELAY OF MODIFICATION OF COST SHARING REQUIREMENTS FOR CERTAIN EXPANSION INDIVIDUALS UNDER THE MEDICAID PROGRAM.

    (a) In General.--Section [struck: 1192(e)][inserted: 1916] of the Social Security Act (42 U.S.C. [struck: 1320f-1(e][inserted: 1396o])[struck: ) ][inserted: , as amended by section 71122, ]is [inserted: further ]amended[struck: --][inserted: by striking "October 1, 2028" each place it appears and inserting "October 1, 2032".]

    Struck: (1) in paragraph (1), in the matter preceding subparagraph (A), by striking "and (3)" and inserting "through (4)";

    Struck: (2) in paragraph (3)(A)--

    Struck: (A) by striking "only one rare disease or condition" and inserting "one or more rare diseases or conditions"; and

    Struck: (B) by striking "such disease or condition" and inserting "one or more such rare diseases or conditions (as such term is defined in section 526(a)(2) of the Federal Food, Drug, and Cosmetic Act)"; and

    Show 3 more struck paragraphs

    Struck: (3) by adding at the end the following new paragraph:

    Struck: "(4) Treatment of former orphan drugs.--In the case of a drug or biological product that, as of the date of the approval or licensure of such drug or biological product, is a drug or biological product described in paragraph (3)(A), paragraph (1)(A)(ii) or (1)(B)(ii) (as applicable) shall apply as if the reference to 'the date of such approval' or 'the date of such licensure', respectively, were instead a reference to 'the first day after the date of such approval for which such drug is not a drug described in paragraph (3)(A)' or 'the first day after the date of such licensure for which such biological product is not a biological product described in paragraph (3)(A)', respectively.".

    Struck: (b) Application.--The amendments made by subsection (a) shall apply with respect to initial price applicability years (as defined in section 1191(b) of the Social Security Act (42 U.S.C. 1320f(b))) beginning on or after January 1, 2028.

    Inserted: (b) Medicare Improvement Fund.--Section 1898(b)(1) of the Social Security Act (42 U.S.C. 1395iii(b)(1)) is amended by striking "$1,804,000,000" and inserting "$1,788,000,000".

    Original wording

    Strike section 71203, and insert the following:

Read automatically from the Congressional Record. Check the original before relying on it.

As printed

SA 2846. Mr. WELCH submitted an amendment intended to be proposed to amendment SA 2360 proposed by Mr. Thune (for Mr. Graham) to the bill H.R. 1, to provide for reconciliation pursuant to title II of H. Con. Res. 14; which was ordered to lie on the table; as follows:

Strike section 71203, and insert the following:

SEC. 71203. DELAY OF MODIFICATION OF COST SHARING REQUIREMENTS FOR CERTAIN EXPANSION INDIVIDUALS UNDER THE MEDICAID PROGRAM.

(a) In General.--Section 1916 of the Social Security Act (42 U.S.C. 1396o), as amended by section 71122, is further amended by striking “October 1, 2028” each place it appears and inserting “October 1, 2032”.

(b) Medicare Improvement Fund.--Section 1898(b)(1) of the Social Security Act (42 U.S.C. 1395iii(b)(1)) is amended by striking “$1,804,000,000” and inserting “$1,788,000,000”.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

Floor Latest Action

Senate amendment submitted

July 1, 2025